Tumor microenvironment: barrier or opportunity towards effective cancer therapy

A Tiwari, R Trivedi, SY Lin - Journal of biomedical science, 2022 - Springer
Tumor microenvironment (TME) is a specialized ecosystem of host components, designed
by tumor cells for successful development and metastasis of tumor. With the advent of 3D …

The emerging clinical relevance of genomics in cancer medicine

MF Berger, ER Mardis - Nature reviews Clinical oncology, 2018 - nature.com
The combination of next-generation sequencing and advanced computational data analysis
approaches has revolutionized our understanding of the genomic underpinnings of cancer …

Multi-omic machine learning predictor of breast cancer therapy response

SJ Sammut, M Crispin-Ortuzar, SF Chin, E Provenzano… - Nature, 2022 - nature.com
Breast cancers are complex ecosystems of malignant cells and the tumour
microenvironment. The composition of these tumour ecosystems and interactions within …

[HTML][HTML] SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity

C Motozono, M Toyoda, J Zahradnik, A Saito… - Cell host & …, 2021 - cell.com
Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These
mutations can affect viral properties such as infectivity and immune resistance. Although the …

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

D Hammerl, JWM Martens, M Timmermans… - Nature …, 2021 - nature.com
Only a subgroup of triple-negative breast cancer (TNBC) responds to immune checkpoint
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …

Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates

Y Simoni, E Becht, M Fehlings, CY Loh, SL Koo… - Nature, 2018 - nature.com
Various forms of immunotherapy, such as checkpoint blockade immunotherapy, are proving
to be effective at restoring T cell-mediated immune responses that can lead to marked and …

NetMHCpan-4.0: improved peptide–MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data

V Jurtz, S Paul, M Andreatta, P Marcatili… - The Journal of …, 2017 - journals.aai.org
Cytotoxic T cells are of central importance in the immune system's response to disease.
They recognize defective cells by binding to peptides presented on the cell surface by MHC …

An immunogenic personal neoantigen vaccine for patients with melanoma

PA Ott, Z Hu, DB Keskin, SA Shukla, J Sun, DJ Bozym… - Nature, 2017 - nature.com
Effective anti-tumour immunity in humans has been associated with the presence of T cells
directed at cancer neoantigens, a class of HLA-bound peptides that arise from tumour …

Evolution of neoantigen landscape during immune checkpoint blockade in non–small cell lung cancer

V Anagnostou, KN Smith, PM Forde, N Niknafs… - Cancer discovery, 2017 - AACR
Immune checkpoint inhibitors have shown significant therapeutic responses against tumors
containing increased mutation-associated neoantigen load. We have examined the evolving …

Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells

CJ Turtle, LA Hanafi, C Berger, M Hudecek… - Science translational …, 2016 - science.org
CD19-specific chimeric antigen receptor (CAR)–modified T cells have antitumor activity in B
cell malignancies, but factors that affect toxicity and efficacy have been difficult to define …